FAAH inhibitors (Maruishi)

N/A

Report date: 2025/01/15 13:55:03
NME

Base Information

Drug NameFAAH inhibitors (Maruishi)
Drug Alias NameFAAH inhibitors (Sumitomo Dainippon Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitors
TargetsAnandamide amidohydrolase
Therapy Area/IndicationsCognition DisordersVomitingNausea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsVomitingNausea
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A